Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03071276
Title Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

Cytarabine + Fludarabine + Methotrexate + Prednisone + Selinexor

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.